Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03612232
Title Cabozantinib in Advanced Adrenocortical Carcinoma (CaboACC)
Acronym CaboACC
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Wuerzburg University Hospital
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.